Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece - Top-Institutions - MDSpire

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

  • By

  • Charalampos Tzanetakos

  • Vasiliki-Rafaela Vakouftsi

  • George Mavridoglou

  • Andriani Angelopoulou

  • George Gourzoulidis

  • July 10, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Hellenic Society of Crohn’s disease and Ulcerative Colitis (HELLESCC)
    Hellenic Society of Crohn’s disease and Ulcerative Colitis (HELLESCC)

    Athens, Greece

    Key Differentiators

    • Gastroenterology

  • #2

    Copenhagen Capital Region
    Copenhagen Capital Region

    Copenhagen, Denmark

    Key Differentiators

    • Gastroenterology

  • #3

    YOURS registry
    YOURS registry

    N/A, N/A

    Key Differentiators

    • Gastroenterology

Original Source(s)

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

  • by Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Andriani Angelopoulou, George Gourzoulidis

  • July 10, 2026

Related Content

NIH researchers identify regulatory cells that shield against inflammatory bowel disease

  • June 8, 2026

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance